Viewbix Announces the Closing of Strategic Acquisition of Quantum X Labs – An Emerging Leader of Quantum Technologies

Viewbix (NASDAQ: VBIX) completed the acquisition of 100% of Quantum X Labs on March 4, 2026, acquiring Quantum’s IP including an AI-Quantum Error Correction patent and quantum navigation, clocks, and algorithms.

Rhea-AI Summary

Viewbix (NASDAQ: VBIX) completed the acquisition of 100% of Quantum X Labs on March 4, 2026, acquiring Quantum’s IP including an AI-Quantum Error Correction patent and quantum navigation, clocks, and algorithms.

Viewbix issued common stock and pre-funded warrants representing approximately 40% of its capital stock as of the agreement date, including 800,000 shares sold in a related private placement that generated approximately $1.4 million gross proceeds. The deal includes up to 12,702,847 additional shares or pre-funded warrants contingent on post-closing milestones.

Positive

• 100% acquisition of Quantum X Labs completed on March 4, 2026
• Acquired proprietary IP including AI-Quantum Error Correction patent
• Issued equity/warrants representing ~40% of capital stock (Agreement Date)
• Raised approximately $1.4 million via private placement

Negative

• Issued equity representing ~40% of capital stock, causing significant dilution
• Contingent issuance up to 12,702,847 shares may cause further dilution
• 640,000 warrants exercisable for common stock could increase share count

Argus Mar 4 session

-3.98% close to close Open Argus

Details

News Market Reaction – VBIX

On Mar 4, the day this news came out, VBIX closed 3.98% below the previous close.

Data tracked by StockTitan Argus for the Mar 4 session.

Market Context

This announcement finalizes VBIX’s long-telegraphed acquisition of 100% of Quantum X Labs, bringing ...

Analysis

This announcement finalizes VBIX’s long-telegraphed acquisition of 100% of Quantum X Labs, bringing a portfolio of quantum navigation, atomic clock, and error-correction technologies under its umbrella. The deal closes alongside a $1.4 million private placement, involving 800,000 new shares and 640,000 warrants, and includes potential earn-out issuances up to 12,702,847 additional shares or warrants. Investors may watch how integration progresses and how future milestone-triggered dilution is managed.

Key Figures

Acquisition stake: 100% of Quantum X Labs Initial equity issuance: 40% of capital stock Earn-out securities: Up to 12,702,847 shares/warrants +5 more

Acquisition stake

100% of Quantum X Labs

Ownership acquired at closing on March 4, 2026

Initial equity issuance

40% of capital stock

Common stock and pre-funded warrants as of Dec 15, 2025

Earn-out securities

Up to 12,702,847 shares/warrants

Contingent on specified post-closing milestones

Private placement shares

800,000 common shares

Issued at $1.75 per share in concurrent financing

Share price in placement

$1.75 per share

Price for 800,000 common shares in private placement

Common warrants issued

640,000 warrants

Each exercisable for 1 share at $2.625

Warrant exercise price

$2.625 per share

Exercise price of common warrants, 5-year term

Gross proceeds

Approximately $1.4 million

Aggregate gross proceeds from March 4, 2026 private placement

Previous Acquisition Reports

5 past events · Latest: Feb 23

Same Type 5 events

1. Feb 23

   Definitive agreement details

   24h Move

   -1.8%

   Outlined definitive Quantum X Labs acquisition terms and amended private placement structure.

2. Jan 08

   Agreement reaffirmed

   24h Move

   -3.5%

   Reiterated plan to acquire 85–100% of Quantum X Labs and related IP portfolio.

3. Jan 05

   Stockholder approval

   24h Move

   +4.3%

   Received majority stockholder consent for Quantum X Labs acquisition and equity issuance terms.

4. Dec 16

   Definitive deal signed

   24h Move

   -24.8%

   Signed definitive agreement to acquire 85–100% of Quantum X Labs with large equity issuance.

5. Nov 14

   Term sheet revised

   24h Move

   +2.5%

   Updated non-binding term sheet for 100% Quantum X Labs acquisition with 40% initial equity.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

pre-funded warrants, private placement, common warrants, registration statement, +2 more

6 terms

pre-funded warrants financial

"issued common stock and pre-funded warrants representing approximately 40% of its capital"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

private placement financial

"800,000 shares of common stock issued in a related private placement"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

common warrants financial

"the Company issued an aggregate of 640,000 common warrants, each exercisable for one share"

A common warrant is a tradable instrument that gives its holder the right to buy a company’s common shares at a fixed price within a set time period, similar to a coupon that can be redeemed later to purchase stock. Investors care because exercising warrants can boost potential gains if the stock rises, but it can also dilute existing shareholders by increasing the number of shares outstanding, which can lower per-share value.

registration statement regulatory

"may not be reoffered or resold in the United States except pursuant to an effective registration statement"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

accredited investors regulatory

"The securities were offered only to accredited investors."

Accredited investors are individuals or entities considered to have enough financial knowledge and resources to understand and handle more complex and risky investments. They are often allowed to participate in private investment opportunities that are not available to the general public, similar to how experienced players might access exclusive clubs or events. This status helps ensure that investors can manage potential risks and rewards appropriately.

quantum error correction technical

"including an innovative patent for AI-Quantum Error Correction."

Quantum error correction is a set of methods for detecting and fixing mistakes in quantum computers by encoding fragile quantum information across multiple physical parts, much like using multiple copies or checksums to protect a sensitive digital file. For investors, it matters because reliable error correction is a key technical milestone that determines whether quantum machines can scale from experimental devices to practical tools that could disrupt computing, encryption, drug discovery and other industries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

The acquisition encompasses Quantum’s proprietary intellectual property portfolio, including an innovative patent for AI-Quantum Error Correction

Tel Aviv, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that it has completed the acquisition of 100% of Quantum X Labs Ltd. (“Quantum”), a multi-disciplinary quantum technology hub focused on quantum algorithms, navigation, and atomic clocks, pursuant to the definitive share purchase agreement dated December 15, 2025 (the “Agreement Date”).

The acquisition encompasses Quantum’s proprietary intellectual property portfolio, including an innovative patent for AI-Quantum Error Correction.

Quantum operates portfolio companies developing innovative solutions in quantum-based navigation (including GPS alternatives), next-generation atomic clocks for precision timing, quantum algorithms for sectors such as transportation, drug discovery, biomedicine, and security, as well as advanced quantum error correction technologies.

In connection with the closing, Viewbix issued common stock and pre-funded warrants representing approximately 40% of its capital stock as of the Agreement Date (inclusive of 800,000 shares of common stock issued in a related private placement), with potential additional consideration of up to 12,702,847 shares of the Company’s common stock or pre-funded warrants upon achievement of specified post-closing milestones.

In addition to the closing of the Quantum acquisition, Viewbix also closed a private placement of approximately $1.4 million shares of the Company’s common stock and warrants to purchase common stock.

In connection with the private placement, the Company issued an aggregate of 800,000 shares of common stock at a price of $1.75 per share. In addition, the Company issued an aggregate of 640,000 common warrants, each exercisable for one share of common stock, at an exercise price of $2.625 per share to the investors in the private placement for no additional consideration. The common warrants are exercisable upon issuance and have a term of 5 years from the issuance date.

Aggregate gross proceeds to the Company were approximately $1.4 million, before deducting offering expenses payable by the Company. The Company expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital.

The closing of the Quantum acquisition and private placement occurred on March 4, 2026. 

The securities described above were issued and/or sold in private placement transactions not involving a public offering and exempt from the registration requirements of the Securities Act of 1933, as amended (the "Act"), and have not been registered under the Act, or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws. The securities were offered only to accredited investors.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Viewbix Inc.

Viewbix, through certain of its subsidiaries Gix Media Ltd. and Metagramm Software Ltd., operates in the field of digital advertising. Gix Media develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software. The company offers tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.

For more information about Viewbix, visit https://view-bix.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the achievement of specified post-closing milestones and the intended use of proceeds from the private placement. Because such statements deal with future events and are based on Viewbix’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix is not responsible for the contents of third-party websites.

Investor Relations Contacts:
Michal Efraty
Investor Relations
michal@efraty.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Viewbix (VBIX) acquire from Quantum X Labs on March 4, 2026?

Viewbix acquired 100% of Quantum X Labs and its proprietary IP including an AI-Quantum Error Correction patent. According to the company, the acquisition adds quantum navigation, atomic clocks, and algorithms aimed at transportation, drug discovery, biomedicine, and security.

How much equity did Viewbix issue in the Quantum X Labs acquisition (VBIX)?

Viewbix issued common stock and pre-funded warrants representing approximately 40% of its capital stock as of the agreement date. According to the company, that issuance included 800,000 shares sold in a related private placement.

What are the financial terms of Viewbix’s private placement related to the acquisition (VBIX)?

The private placement generated approximately $1.4 million in gross proceeds from 800,000 shares priced at $1.75 each. According to the company, the placement also included 640,000 common warrants exercisable at $2.625 for five years.

Could the Quantum acquisition trigger future dilution for VBIX shareholders?

Yes, the acquisition includes potential additional consideration of up to 12,702,847 shares or pre-funded warrants contingent on milestones. According to the company, these contingencies could increase share count if milestones are achieved.

When did the Quantum X Labs acquisition and private placement close for VBIX?

Both the Quantum X Labs acquisition and the related private placement closed on March 4, 2026. According to the company, the securities were issued in private placements exempt from registration and offered only to accredited investors.

What are the exercise terms of the warrants issued in Viewbix’s private placement (VBIX)?

The company issued 640,000 common warrants exercisable for one share each at an exercise price of $2.625 per share for five years. According to the company, the warrants are exercisable upon issuance with a five-year term.